These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22982181)

  • 1. Co-expression of estrogen receptor beta and aromatase in Japanese lung cancer patients: gender-dependent clinical outcome.
    Verma MK; Miki Y; Abe K; Nagasaki S; Niikawa H; Suzuki S; Kondo T; Sasano H
    Life Sci; 2012 Oct; 91(15-16):800-8. PubMed ID: 22982181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma.
    Niikawa H; Suzuki T; Miki Y; Suzuki S; Nagasaki S; Akahira J; Honma S; Evans DB; Hayashi S; Kondo T; Sasano H
    Clin Cancer Res; 2008 Jul; 14(14):4417-26. PubMed ID: 18579664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoplasmic estrogen receptor β as a potential marker in human non-small cell lung carcinoma.
    Verma MK; Miki Y; Abe K; Niikawa H; Sasano H
    Expert Opin Ther Targets; 2012 Mar; 16 Suppl 1():S91-102. PubMed ID: 22313325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer.
    Skjefstad K; Grindstad T; Khanehkenari MR; Richardsen E; Donnem T; Kilvaer T; Andersen S; Bremnes RM; Busund LT; Al-Saad S
    Steroids; 2016 Sep; 113():5-13. PubMed ID: 27234503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of aromatase inhibitors and antiestrogens on estrogen receptor expression in breast cancer cells.
    Smollich M; Götte M; Fischgräbe J; Radke I; Kiesel L; Wülfing P
    Anticancer Res; 2009 Jun; 29(6):2167-71. PubMed ID: 19528477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer.
    Mah V; Marquez D; Alavi M; Maresh EL; Zhang L; Yoon N; Horvath S; Bagryanova L; Fishbein MC; Chia D; Pietras R; Goodglick L
    Lung Cancer; 2011 Nov; 74(2):318-25. PubMed ID: 21511357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase inhibitors in human lung cancer therapy.
    Weinberg OK; Marquez-Garban DC; Fishbein MC; Goodglick L; Garban HJ; Dubinett SM; Pietras RJ
    Cancer Res; 2005 Dec; 65(24):11287-91. PubMed ID: 16357134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral localization and activity of 17β-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer: a potent prognostic factor.
    Verma MK; Miki Y; Abe K; Suzuki T; Niikawa H; Suzuki S; Kondo T; Sasano H
    J Transl Med; 2013 Jul; 11():167. PubMed ID: 23837683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly concordant coexpression of aromatase and estrogen receptor beta in non-small cell lung cancer.
    Abe K; Miki Y; Ono K; Mori M; Kakinuma H; Kou Y; Kudo N; Koguchi M; Niikawa H; Suzuki S; Evans DB; Sugawara S; Suzuki T; Sasano H
    Hum Pathol; 2010 Feb; 41(2):190-8. PubMed ID: 19800101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral concentration of estrogens and clinicopathological changes in ductal carcinoma in situ following aromatase inhibitor letrozole treatment.
    Takagi K; Ishida T; Miki Y; Hirakawa H; Kakugawa Y; Amano G; Ebata A; Mori N; Nakamura Y; Watanabe M; Amari M; Ohuchi N; Sasano H; Suzuki T
    Br J Cancer; 2013 Jul; 109(1):100-8. PubMed ID: 23756858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer.
    Siegfried JM; Farooqui M; Rothenberger NJ; Dacic S; Stabile LP
    Oncotarget; 2017 Apr; 8(15):24063-24076. PubMed ID: 28445992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking out reproductive hormone actions in lung cancer.
    Siegfried JM
    Mol Cancer Res; 2014 Jan; 12(1):24-31. PubMed ID: 24398390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer.
    Lykkesfeldt AE; Henriksen KL; Rasmussen BB; Sasano H; Evans DB; Møller S; Ejlertsen B; Mouridsen HT
    BMC Cancer; 2009 Jun; 9():185. PubMed ID: 19531212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synergistic effect of EGFR tyrosine kinase inhibitor gefitinib in combination with aromatase inhibitor anastrozole in non-small cell lung cancer cell lines.
    Shen L; Li Z; Shen S; Niu X; Yu Y; Li Z; Liao M; Chen Z; Lu S
    Lung Cancer; 2012 Dec; 78(3):193-200. PubMed ID: 22985911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral localization of aromatase and interaction between stromal and parenchymal cells in the non-small cell lung carcinoma microenvironment.
    Miki Y; Suzuki T; Abe K; Suzuki S; Niikawa H; Iida S; Hata S; Akahira J; Mori K; Evans DB; Kondo T; Yamada-Okabe H; Sasano H
    Cancer Res; 2010 Aug; 70(16):6659-69. PubMed ID: 20710045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting aromatase and estrogen signaling in human non-small cell lung cancer.
    Márquez-Garbán DC; Chen HW; Goodglick L; Fishbein MC; Pietras RJ
    Ann N Y Acad Sci; 2009 Feb; 1155():194-205. PubMed ID: 19250205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of estrogen actions in human lung cancer.
    Miki Y; Abe K; Suzuki S; Suzuki T; Sasano H
    Mol Cell Endocrinol; 2011 Jul; 340(2):168-74. PubMed ID: 21354461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands.
    Hershberger PA; Vasquez AC; Kanterewicz B; Land S; Siegfried JM; Nichols M
    Cancer Res; 2005 Feb; 65(4):1598-605. PubMed ID: 15735050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERβ localization influenced outcomes of EGFR-TKI treatment in NSCLC patients with EGFR mutations.
    Wang Z; Li Z; Ding X; Shen Z; Liu Z; An T; Duan J; Zhong J; Wu M; Zhao J; Zhuo M; Wang Y; Wang S; Sun Y; Bai H; Wang J
    Sci Rep; 2015 Jun; 5():11392. PubMed ID: 26096604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of estrogen-related gene markers in breast cancer tissue predicts aromatase inhibitor responsiveness.
    Moy I; Lin Z; Rademaker AW; Reierstad S; Khan SA; Bulun SE
    PLoS One; 2013; 8(11):e77543. PubMed ID: 24223121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.